Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Synthesis series

Network meta-analysis

An indirect and mixed-treatment comparison across interventions connected by a common comparator. Transitivity is assessed explicitly and reported before any estimate is presented.

All typesIntervention review (76)Network meta-analysis (2)Safety review (45)Methodological review (6)Analytical evidence review (7)Scoping review (4)

Reviews

2 documents
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.